Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis

doi:10.3748/wjg.v24.i40.4606

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 40

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7437)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

611

WORD

434

HTML

3490

Figures (1-3)

171

Tables (1-2)

208

Sum=4914

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

940

Download

1583

Sum=2523

Oct 28, 2018 (publication date) through Jul 5, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Oct 28, 2018; 24(40): 4606-4614
Published online Oct 28, 2018. doi: 10.3748/wjg.v24.i40.4606

Full Size Figure Download Figure

Figure 2 Clinical course of chronic hepatitis B patients receiving antiviral agents. CHB: Chronic hepatitis B. HCC: Hepatocellular carcinoma.

Citation: Ju YC, Jun DW, Choi J, Saeed WK, Lee HY, Oh HW. Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis. World J Gastroenterol 2018; 24(40): 4606-4614
URL: https://www.wjgnet.com/1007-9327/full/v24/i40/4606.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i40.4606